Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13877
Country/Region: Uganda
Year: 2016
Main Partner: Children's AIDS Fund International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,022,837 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $671,210
Care: Orphans and Vulnerable Children (HKID) $546,365
Care: TB/HIV (HVTB) $159,491
Care: Pediatric Care and Support (PDCS) $164,278
Testing: HIV Testing and Counseling (HVCT) $84,791
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $19,166
Treatment: Adult Treatment (HTXS) $1,318,742
Treatment: Pediatric Treatment (PDTX) $58,794
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 2
GEND_GBV Age/Sex: <10 Male 2017 1
GEND_GBV Age/Sex: 10-14 Female 2017 11
GEND_GBV Age/Sex: 10-14 Male 2017 1
GEND_GBV Age/Sex: 15-19 Female 2017 19
GEND_GBV Age/Sex: 15-19 male 2017 2
GEND_GBV Age/Sex: 20-24 Female 2017 29
GEND_GBV Age/Sex: 20-24 Male 2017 2
GEND_GBV Age/Sex: 25-49 Female 2017 8
GEND_GBV Age/Sex: 25-49 Male 2017 2
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 6
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 17
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 60
GEND_GBV Number of people receiving post-GBV care 2017 77
GEND_GBV Sum of Age/Sex Disaggregates 2017 15
HTS_TST Age/sex: <1 2017 432
HTS_TST Age/sex: 1-9 2017 1,434
HTS_TST Age/sex: 10-14 Female 2017 1,239
HTS_TST Age/sex: 10-14 Male 2017 1,235
HTS_TST Age/sex: 15-19 Female 2017 3,070
HTS_TST Age/sex: 15-19 Male 2017 3,382
HTS_TST Age/sex: 20-24 Female 2017 4,604
HTS_TST Age/sex: 20-24 Male 2017 5,075
HTS_TST Age/sex: 25-49 Female 2017 7,059
HTS_TST Age/sex: 25-49 Male 2017 7,779
HTS_TST Age/sex: 50+ Female 2017 613
HTS_TST Age/sex: 50+ Male 2017 676
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,174
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 2,166
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 15,346
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 16,912
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 36,598
HTS_TST Service Delivery Point (Facility): Index testing 2017 4,825
HTS_TST Service Delivery Point (Facility): Inpatient 2017 11,803
HTS_TST Service Delivery Point (Facility): Other PITC 2017 3,135
HTS_TST Service Delivery Point (Facility): Outpatient 2017 10,778
HTS_TST Service Delivery Point (Facility): Pediatric 2017 4,272
HTS_TST Service Delivery Point (Facility): PMTCT 2017 1,327
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 458
HTS_TST Sum of Age/Sex disaggregates 2017 34,732
HTS_TST Sum of Aggregated Age/Sex <15 2017 4,340
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 32,258
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 36,598
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 56
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 53
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 156
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 119
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 233
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 182
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 357
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 276
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 30
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 24
HTS_TST_POS Test Result by Age: Positive: <1 2017 20
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 63
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 99
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 93
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 776
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 601
OVC_SERV Age/Sex: 18+ Female 2017 1,172
OVC_SERV Age/Sex: 18+ Male 2017 965
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 3,338
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 3,122
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 8,597
OVC_SERV Sum of Age/Sex disaggregates 2017 2,137
PMTCT_ART Already on ART at beginning of current pregnancy 2017 45
PMTCT_ART New on ART 2017 34
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,341
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 55
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 14
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 1
PMTCT_EID Sum of Infant Age disaggregates 2017 69
PMTCT_STAT By: Known positives at entry 2017 48
PMTCT_STAT By: Number of new positives identified 2017 37
PMTCT_STAT Number of new ANC and L&D clients 2017 1,374
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,341
PMTCT_STAT Sum of Positives Status disaggregates 2017 85
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 41
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 84
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 128
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 128
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,358
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 235
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 708
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,415
TB_SCREENDX Screen Result: Screened Positive for TB 2017 589
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 18,344
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 9,447
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 893
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 792
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 29,476
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 98
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 181
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 296
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 296
TX_CURR Age/Sex: <1 2017 67
TX_CURR Age/Sex: <1-9 2017 404
TX_CURR Age/Sex: 10-14 Female 2017 652
TX_CURR Age/Sex: 10-14 Male 2017 562
TX_CURR Age/Sex: 15-19 Female 2017 916
TX_CURR Age/Sex: 15-19 Male 2017 283
TX_CURR Age/Sex: 20-24 Female 2017 4,219
TX_CURR Age/Sex: 20-24 Male 2017 1,890
TX_CURR Age/Sex: 25-49 Female 2017 12,293
TX_CURR Age/Sex: 25-49 Male 2017 6,802
TX_CURR Age/Sex: 50+ Female 2017 916
TX_CURR Age/Sex: 50+ Male 2017 472
TX_CURR Aggregated Age/Sex: <15 Female 2017 893
TX_CURR Aggregated Age/Sex: <15 Male 2017 792
TX_CURR Aggregated Age/Sex: 15+ Female 2017 18,344
TX_CURR Aggregated Age/Sex: 15+ Male 2017 9,447
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 29,476
TX_CURR Sum of age/sex disaggregates 2017 1,199
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,685
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 27,791
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 29,476
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 147
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 129
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,082
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,075
TX_NEW By Age/Sex: <1 2017 10
TX_NEW By Age/Sex: 1-9 2017 68
TX_NEW By Age/Sex: 10-14 Female 2017 107
TX_NEW By Age/Sex: 10-14 Male 2017 91
TX_NEW By Age/Sex: 15-19 Female 2017 105
TX_NEW By Age/Sex: 15-19 Male 2017 32
TX_NEW By Age/Sex: 20-24 Female 2017 479
TX_NEW By Age/Sex: 20-24 Male 2017 215
TX_NEW By Age/Sex: 25-49 Female 2017 1,395
TX_NEW By Age/Sex: 25-49 Male 2017 774
TX_NEW By Age/Sex: 50+ Female 2017 103
TX_NEW By Age/Sex: 50+ Male 2017 54
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,433
TX_NEW Sum of Age/Sex disaggregates 2017 3,355
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 3,433
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 23,580
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 21,222
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 643
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 571
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 13,202
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 6,806
TX_PVLS Numerator: Indication: Routine 2017 21,222
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 715
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 634
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 14,671
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 7,560
TX_PVLS_den Denominator: Indication: Routine 2017 23,580
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 42
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 62
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 72
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 68
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 86
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 304
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 885
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,013
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 65
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 677
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 82
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 98
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,322
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,794
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,296
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,826
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 48
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 68
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 79
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 74
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 343
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 627
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 996
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,260
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 73
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 159
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 91
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 109
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,486
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,140